Global Ophthalmology Therapeutics Market Report to 2018 - Ophthalmology Therapeutics Market to 2018 – Dosing Convenience and Cost-effectiveness

RnR Market Research, the leading business intelligence provider, has released its latest research, Ophthalmology Therapeutics Market to 2018 – Dosing Convenience and Cost-effectiveness Continue to Drive Eylea’s Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD)”", which provides insights into the global ophthalmology therapeutics market, with forecasts until 2018. The report provides an in-depth analysis of the key therapeutic indications of ophthalmology, namely glaucoma, allergic conjunctivitis, Dry Eye Syndrome (DES), Diabetic Macular Edema (DME), and Wet Age Macular Degeneration (Wet-AMD). The report also examines the ophthalmology therapeutics treatment usage patterns for the covered indications. In addition, the report includes insights into the ophthalmology R&D pipeline.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Buy your copy of this report @ http://www.rnrmarketresearch.com/ophthalmology-therapeutics-market-to-2018-dosing-convenience-and-cost-effectiveness-continue-to-drive-eyleas-prescription-share-in-wet-age-related-macular-degeneration-wet-amd-market-report.html

In 2011, the global ophthalmology therapeutics market was estimated to be around $10 billion, growing at a Compound Annual Growth Rate (CAGR) of 7.2% between 2004 and 2011. The glaucoma market was the largest segment followed by Wet-AMD. These segments accounted for 36% and 32% of the global ophthalmology therapeutics market in 2011, respectively. The decline in glaucoma revenue due to significant generic erosion will change the therapeutic landscape until 2018, when glaucoma is expected to account for 23%, a decline of 13% relative to 2011, and the wet-AMD market is expected to account for 37% of the global ophthalmology market, an increase of 5% relative to 2011. The decline in the glaucoma market is expected to be offset by a healthy growth in the wet-AMD, DME, and DES markets. These markets are expected to grow due to the presence of considerable unmet need and increasing treatment-seeking and diagnosis rates.

The top pharmaceutical companies in the ophthalmology market are Pfizer Inc., Allergan Inc., Alcon Inc, Novartis AG., Merck & co. Inc and Roche. Approximately 70% of the market is covered by these six companies.

Scope

• The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the glaucoma, allergic conjunctivitis, DES, DME, and wet-AMD therapeutics market.
•  Data and analysis for the global ophthalmology therapeutics market
• Annualized market data for the ophthalmology therapeutics market from 2004 to 2011, with forecasts to 2018
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the global ophthalmology therapeutics market
• Key M&A activities and licensing agreements that took place in the ophthalmology therapeutics market

Reasons to buy

• Align your product portfolio to the markets with high growth potential
• Develop market entry and market expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
• Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the ophthalmology market
• Develop key strategic initiatives by understanding the key focus areas and leading companies
• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

                                          

United Arab Emirates Water Report Q4 2012

BMI View: Abu Dhabi did not let water policy drift over the traditionally quiet summer months, and the confirmation of the plans for a new independent water and power project (IWPP) at Mirfa is a tonic for the sector and for international developers looking for project opportunities in the UAE. It remains to be seen what approach Dubai will adopt over our five-year forecast period; the emirate’s economy is starting to revive after a troubled three years, following the Dubai World debt crisis. Water demand should start to regain its historic trend, and the emirate’s authorities will need to find a solution to how it wants to finance the necessary investment.

Get your copy of this report @ http://www.rnrmarketresearch.com/united-arab-emirates-water-report-q4-2012-market-report.html

Key themes to highlight for UAE’s water sector:

After some mixed news for privately financed power and water projects in the UAE – headed by Dubai Electricity & Water Authority’s (DEWA’s) controversial cancellation of an independent power project (IPP) early in 2012 – the announcement of a new independent water and power project in Abu Dhabi will restore some confidence among private water developers.
The new IWPP at Mirfa, sponsored by Abu Dhabi Water & Electricity Authority (ADWEA),
will have a 53mn gallons-a-day (g/d) water desalination capacity, as well as 1,500 megawatts
(MW) of electricity generation. A 40% stake will be offered to the successful foreign bidder,
with a plant completion deadline set for 2016.

ADWEA is refinancing the debt on the Suweihat II IWPP, with plans to issue an US$800bn
bond, which would be used to repay some of the bank loans ahead of schedule, and then secure new loans at lower interest rates. Some lenders are expected to accept repayment terms rather than commit to lower interest rates.

In summer 2012, the UK’s Mott MacDonald won an estimated AED2bn consultancy contract
for services on building a pumping station as part of ADSSC’s Strategic Tunnels Enhancement
Programme (Step). The pumping station will have a 3.3mn m3/d capacity, which will assist
 
ADSSC complete the upgrade of the emirate’s sewage system.

Dubai invited bids for an extended 26 August deadline on a contract to build water reservoirs
with a 120mn gallon capacity at Lusaily. Bidders are mainly Gulf and Indian firms. Another
120mn gallon reservoir at Ghafat is due for completion in 2012.

We have scaled back the amount of water we believe the UAE will produce over our five-year
forecast period to 2016. Though demand remains robust (Dubai apart) across the federation, we no longer expect production to break the 200,000mn gallon level by the end of our forecast
period in 2016. With the Mirfa IWPP due onstream that year, adding 53mn g/d of capacity to the Abu Dhabi water system, there will be an increase in capacity. However, this is some 7mn g/d short of the original target level, and leads us to revise down our production outlook. We still
United Arab Emirates Water Report Q4 2012 © Business Monitor International Ltd Page 6
expect the UAE’s focus on private water development to ensure that supply will keep pace with
demand, but much will depend on ADWEA’s ability to push through planned increases. So far,
its strategy is holding up well, giving us confidence in the future of the emirate’s water sector.

Report Details:

Published: Oct 2012

No. of pages: 60

Price: Single User License: US $1175

                                           

Beauty and Personal Care Market Research in Pakistan

With strong marketing campaigns of major market players enticing customers to spend more on beauty and personal care and increasing distribution awareness of beauty and personal care products across geographical and socioeconomic divisions, the industry experienced above-average growth in 2011 as compared to the review period. The huge growth is also due to growing urbanisation and population growth that have expanded the potential consumer base for beauty products.

Mass brands outperformed the premium products such as designer fragrances and high-end cosmetics available in the market in 2011. In a low-income country with a very small high-income group located mostly in large cities, the consumer base for mass products grew at a faster pace than that of premium products. For the majority of the population, most premium products are out of their reach due to high prices and low availability. Manufacturers mostly offered products that are affordable to the masses in an attempt to reach out to a wider consumer base. 

Product coverage: Baby and Child-specific Products, Bath and Shower, Colour Cosmetics, Deodorants, Depilatories, Fragrances, Hair Care, Mass Cosmetics, Men's Grooming, Oral Care, Oral Care Excl Power Toothbrushes, Premium Cosmetics, Sets/Kits, Skin Care, Sun Care. 

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Beauty and Personal Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Get your copy of this report @ http://www.rnrmarketresearch.com/beauty-and-personal-care-in-pakistan-market-report.html